Omniscan (Gadodiamide)

Gadodiamide, the active ingredient in Omniscan, is a contrast agent presented as a 0.5 ml/mL solution for intravenous use. It enhances magnetic resonance imaging (MRI) scans to improve visualization of vascular structures and tissue characteristics. GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Omniscan is a gadolinium‑based contrast agent used in magnetic resonance imaging to highlight anatomical details.

- Central nervous system imaging: improves detection of lesions, tumors, and vascular abnormalities. - Cardiovascular MRI: enhances visualization of cardiac chambers, blood flow, and myocardial perfusion. - Whole‑body and oncologic MRI: aids in identifying metastatic disease and assessing tumor vascularity.

Adverse reactions to Omniscan are generally related to its intravenous administration and gadolinium content.

Common Side Effects: - Nausea: mild, transient episodes reported. - Headache: occasional, resolves without intervention. - Injection site discomfort: mild pain or burning at the infusion site. - Warm sensation: brief feeling of warmth during injection. - Dizziness: transient light‑headedness in some patients. - Metallic taste: temporary metallic sensation in the mouth.

Serious or Rare Side Effects: - Nephrogenic systemic fibrosis (NSF): fibrotic skin changes in patients with severe renal impairment. - Anaphylactoid reactions: hives, bronchospasm, or hypotension requiring emergency care. - Severe hypersensitivity: angio‑edema or respiratory distress. - Cardiac arrest: extremely rare but reported in hypersensitive individuals. - Renal toxicity: acute kidney injury in predisposed patients. - Death: rare fatal outcomes linked to severe anaphylaxis or NSF.

When using Omniscan, clinicians should assess patient risk factors and monitor for adverse events.

- Renal function assessment: evaluate glomerular filtration rate before administration. - History of allergies: review prior reactions to contrast media. - Pregnancy considerations: use only if essential, after risk‑benefit analysis. - Pediatric use: adjust dosing based on weight and monitor closely. - Concomitant nephrotoxic drugs: avoid or use with caution. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Omniscan may interact with other agents that affect renal function or immune response.

Major Interactions (Avoid): - Metformin: increased risk of lactic acidosis in renal impairment. - High‑dose iodinated contrast: combined nephrotoxicity risk.\n- Loop‑diuretics: may exacerbate renal insufficiency.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory ​​  ​  ​  ​  ​  ​  ​  ​  ​  ...   -   -  .